Close

ContraVir Pharma (CTRV) Says CMX157 Demonstrates Significant Viral Load Reduction in Phase 2a Study in Hepatitis B

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. HCP
9. V
10. CMG


Go back to ContraVir Pharma (CTRV) Says CMX157 Demonstrates Significant Viral Load Reduction in Phase 2a Study in Hepatitis B